These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26318188)

  • 1. Susceptibility testing challenges with ceftaroline, MRSA and a 1 mg/L breakpoint.
    Livermore DM; Mushtaq S; Warner M; James D; Woodford N
    J Antimicrob Chemother; 2015 Dec; 70(12):3259-66. PubMed ID: 26318188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methodological agreement on the in vitro activity of ceftaroline against cefotaxime-susceptible and -resistant pneumococci.
    Livermore DM; Warner M; Mushtaq S
    Int J Antimicrob Agents; 2014 Feb; 43(2):131-4. PubMed ID: 24361355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of EUCAST ceftaroline breakpoint change on the susceptibility of methicillin-resistant Staphylococcus aureus isolates collected from patients with complicated skin and soft-tissue infections.
    Urbán E; Stone GG
    Clin Microbiol Infect; 2019 Nov; 25(11):1429.e1-1429.e4. PubMed ID: 30980925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Revised Ceftaroline Disk Diffusion Breakpoints When Testing a Challenge Collection of Methicillin-Resistant Staphylococcus aureus Isolates.
    Sader HS; Rhomberg PR; Doyle TB; Flamm RK; Mendes RE
    J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30257898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of MRSA isolates bracketing the current EUCAST ceftaroline-susceptible breakpoint for Staphylococcus aureus: the role of PBP2a in the activity of ceftaroline.
    Lahiri SD; McLaughlin RE; Whiteaker JD; Ambler JE; Alm RA
    J Antimicrob Chemother; 2015 Sep; 70(9):2488-98. PubMed ID: 26045529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic detection of mecC-MRSA: cefoxitin is more reliable than oxacillin.
    Skov R; Larsen AR; Kearns A; Holmes M; Teale C; Edwards G; Hill R
    J Antimicrob Chemother; 2014 Jan; 69(1):133-5. PubMed ID: 24038776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of ceftaroline versus ceftobiprole against staphylococci and pneumococci in the UK and Ireland: analysis of BSAC surveillance data.
    Horner C; Mushtaq S; Livermore DM;
    J Antimicrob Chemother; 2020 Nov; 75(11):3239-3243. PubMed ID: 32728710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium-supplemented daptomycin Etest strips for susceptibility testing on Iso-Sensitest agar.
    Johnson AP; Mushtaq S; Warner M; Livermore DM
    J Antimicrob Chemother; 2004 May; 53(5):860-2. PubMed ID: 15056637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etest® versus broth microdilution for ceftaroline MIC determination with Staphylococcus aureus: results from PREMIUM, a European multicentre study.
    Cantón R; Livermore DM; Morosini MI; Díaz-Regañón J; Rossolini GM;
    J Antimicrob Chemother; 2017 Feb; 72(2):431-436. PubMed ID: 27798220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftaroline efficacy against high-MIC clinical Staphylococcus aureus isolates in an in vitro hollow-fibre infection model.
    Singh R; Almutairi M; Alm RA; Lahiri SD; San Martin M; Chen A; Ambler JE
    J Antimicrob Chemother; 2017 Oct; 72(10):2796-2803. PubMed ID: 29091195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Method-specific performance of vancomycin MIC susceptibility tests in predicting mortality of patients with methicillin-resistant Staphylococcus aureus bacteraemia.
    Chen SY; Liao CH; Wang JL; Chiang WC; Lai MS; Chie WC; Chang SC; Hsueh PR
    J Antimicrob Chemother; 2014 Jan; 69(1):211-8. PubMed ID: 23997017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin MIC susceptibility testing of methicillin-susceptible and methicillin-resistant Staphylococcus aureus isolates: a comparison between Etest® and an automated testing method.
    Bland CM; Porr WH; Davis KA; Mansell KB
    South Med J; 2010 Nov; 103(11):1124-8. PubMed ID: 20890258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogens of skin and skin-structure infections in the UK and their susceptibility to antibiotics, including ceftaroline.
    Livermore DM; Mushtaq S; Warner M; James D; Kearns A; Woodford N
    J Antimicrob Chemother; 2015 Oct; 70(10):2844-53. PubMed ID: 26142478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Multicenter Study To Evaluate Ceftaroline Breakpoints: Performance in an Area with High Prevalence of Methicillin-Resistant Staphylococcus aureus Sequence Type 5 Lineage.
    Khan A; Rivas LM; Spencer M; Martinez R; Lam M; Rojas P; Porte L; Silva F; Braun S; Valdivieso F; Mv Lhauser M; Lafourcade M; Miller WR; García P; Arias CA; Munita JM
    J Clin Microbiol; 2019 Sep; 57(9):. PubMed ID: 31315958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of ceftaroline against mecC-positive MRSA isolates.
    Armengol-Porta M; Tenorio-Abreu A; Bandt D; Coleman DC; Gavier-Widen D; Hotzel H; Kinnevey P; Lazaris A; Peters M; Rangstrup-Christensen L; Schlotter K; Shore AC; Ehricht R; Monecke S
    J Glob Antimicrob Resist; 2016 Jun; 5():3-6. PubMed ID: 27436457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of EUCAST zone diameter breakpoints and quality control range for Staphylococcus aureus with ceftaroline 5-μg disk.
    Koeth LM; Matuschek E; Kahlmeter G; Alm RA; Ambler JE
    Eur J Clin Microbiol Infect Dis; 2014 Sep; 33(9):1511-7. PubMed ID: 24744220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin MIC as a predictor of outcome in MRSA bacteraemia in the UK context.
    Hope R; Blackburn RM; Verlander NQ; Johnson AP; Kearns A; Hill R; Hopkins S; Sheridan E; Livermore DM; ;
    J Antimicrob Chemother; 2013 Nov; 68(11):2641-7. PubMed ID: 23794604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceftaroline Susceptibility among Isolates of MRSA: A Comparison of EUCAST and CLSI Breakpoints.
    Sachu A
    Ethiop J Health Sci; 2023 Jan; 33(1):143-150. PubMed ID: 36890938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity analyses of staphylococcal isolates from pediatric, adult, and elderly patients: AWARE Ceftaroline Surveillance Program.
    Sader HS; Flamm RK; Farrell DJ; Jones RN
    Clin Infect Dis; 2012 Sep; 55 Suppl 3():S181-6. PubMed ID: 22903950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Efficacy of Ceftaroline with Linezolid against Staphylococcus aureus and Methicillin Resistant Staphylococcus aureus.
    Hafeez A; Munir T; Rehman S; Najeeb S; Gilani M; Latif M; Ansari M; Saad N
    J Coll Physicians Surg Pak; 2015 Apr; 25(4):247-9. PubMed ID: 25899187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.